Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer.
JAMA Netw Open
; 5(10): e2235345, 2022 10 03.
Article
em En
| MEDLINE
| ID: mdl-36206000
This cohort study assesses biochemical progression-free survival among patients receiving radiotherapy for the treatment of synchronous oligometastatic prostate cancer.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Radiocirurgia
/
Radioterapia (Especialidade)
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article